Top Markets
Coin of the day
Abingdon Health Plc Abingdon Health Plc

Abingdon Health Plc

ABDX
Classifica tra le azioni #39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Prezzo delle azioni
$0.14287366
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$361.12K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
68.97%
Paese
GB
Scambia Abingdon Health Plc (ABDX)

Categoria

EPS per Abingdon Health Plc (ABDX)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Abingdon Health Plc, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Abingdon Health Plc da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US